GLP-1-BASED THERAPIES BEYOND DIABETES: EMERGING CLINICAL APPLICATIONS AND FUTURE PERSPECTIVES
Background Glucagon-like peptide-1 (GLP-1)-based therapies were initially developed for the treatment of type 2 diabetes mellitus, but their clinical use has expanded substantially because of their effects on body weight and obesity-related complications. GLP-1 receptor agonists, dual and triple receptor agonists, and...